These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9085557)

  • 61. Enantioseparation of aromatic α-hydroxycarboxylic acids: the application of a dinuclear Cu₂(II)-β-cyclodextrin complex as a chiral selector in high speed counter-current chromatography compared with native β-cyclodextrin.
    Han C; Luo J; Xu J; Zhang Y; Zhao Y; Xu X; Kong L
    J Chromatogr A; 2015 Jan; 1375():82-91. PubMed ID: 25512121
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of heptakis (2,3,6-tri-O-methyl)-beta-cyclodextrin with cholesterol in aqueous solution.
    Nishijo J; Moriyama S; Shiota S; Kamigauchi M; Sugiura M
    Chem Pharm Bull (Tokyo); 2004 Dec; 52(12):1405-10. PubMed ID: 15577234
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
    Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M
    Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cooperative self-assembly and molecular binding behavior of cyclodextrin-crown ether conjugates mediated by alkali metal ions.
    Liu Y; Duan ZY; Chen Y; Han JR; Cui L
    Org Biomol Chem; 2004 Aug; 2(16):2359-64. PubMed ID: 15305219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Formation of stable hydrophilic C60 nanoparticles by 2-hydroxypropyl-β-cyclodextrin.
    Iohara D; Hirayama F; Higashi K; Yamamoto K; Uekama K
    Mol Pharm; 2011 Aug; 8(4):1276-84. PubMed ID: 21591726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Two-dimensional 13C-1H heteronuclear correlation NMR spectroscopic studies for the inclusion complex of cyclomaltoheptaose (beta-cyclodextrin) with a new Helicobacter pylori eradicating agent (TG44) in the amorphous state.
    Anzai K; Kono H; Mizoguchi J; Yanagi T; Hirayama F; Arima H; Uekama K
    Carbohydr Res; 2006 Mar; 341(4):499-506. PubMed ID: 16427035
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thermoresponsive Formation of Dimethyl Cyclodextrin Polypseudorotaxanes and Subsequent One-Pot Synthesis of Polyrotaxanes.
    Higashi T; Li J; Song X; Zhu J; Taniyoshi M; Hirayama F; Iohara D; Motoyama K; Arima H
    ACS Macro Lett; 2016 Feb; 5(2):158-162. PubMed ID: 35614691
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
    Irie T; Otagiri M; Sunada M; Uekama K; Ohtani Y; Yamada Y; Sugiyama Y
    J Pharmacobiodyn; 1982 Sep; 5(9):741-4. PubMed ID: 7153847
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibitory effects of dimethylacetyl-beta-cyclodextrin on lipopolysaccharide-induced macrophage activation and endotoxin shock in mice.
    Arima H; Motoyama K; Matsukawa A; Nishimoto Y; Hirayama F; Uekama K
    Biochem Pharmacol; 2005 Nov; 70(10):1506-17. PubMed ID: 16214116
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polypseudorotaxanes of pegylated insulin with cyclodextrins: application to sustained release system.
    Higashi T; Hirayama F; Arima H; Uekama K
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1871-4. PubMed ID: 17291751
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The mechanisms underlying the effect of alpha-cyclodextrin on the aggregation and stability of alcohol dehydrogenase.
    Barzegar A; Moosavi-Movahedi AA; Rezaei-Zarchi S; Saboury AA; Ganjali MR; Norouzi P; Hakimelahi GH; Tsai FY
    Biotechnol Appl Biochem; 2008 Mar; 49(Pt 3):203-11. PubMed ID: 17685894
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Energetics of cyclodextrin-induced dissociation of insulin.
    Lovatt M; Cooper A; Camilleri P
    Eur Biophys J; 1996; 24(5):354-7. PubMed ID: 8766694
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins.
    Ono N; Miyamoto Y; Ishiguro T; Motoyama K; Hirayama F; Iohara D; Seo H; Tsuruta S; Arima H; Uekama K
    J Pharm Sci; 2011 May; 100(5):1935-43. PubMed ID: 21374625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inclusion effect and structural basis of cyclodextrins for increased extraction of medicinal alkaloids from natural medicines.
    Kamigauchi M; Kawanishi K; Ohishi H; Ishida T
    Chem Pharm Bull (Tokyo); 2007 May; 55(5):729-33. PubMed ID: 17473458
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acid-catalyzed hydrolysis of maltosyl-beta-cyclodextrin.
    Hirayama F; Yamamoto M; Uekama K
    J Pharm Sci; 1992 Sep; 81(9):913-6. PubMed ID: 1432639
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment.
    Fundueanu G; Constantin M; Dalpiaz A; Bortolotti F; Cortesi R; Ascenzi P; Menegatti E
    Biomaterials; 2004 Jan; 25(1):159-70. PubMed ID: 14580919
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Physicochemical properties of β-cyclodextrin solutions and precipitates prepared from injectable vehicles.
    Thurein SM; Lertsuphotvanit N; Phaechamud T
    Asian J Pharm Sci; 2018 Sep; 13(5):438-449. PubMed ID: 32104418
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Supramolecular nanomachines for sugar responsive insulin release systems].
    Egawa Y; Seki T
    Yakugaku Zasshi; 2013; 133(12):1287-95. PubMed ID: 24292173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.